Stock screenerAll disclosures →
EDGAR →
PEPG
Conviction 64HealthcareScan · Mon, Aug 10, 2026PEPG$2.98+4.56%
ResistanceSupportVol 14Insider sellVol MA14 1.19M
May 11May 28Jun 16Jul 6Jul 23Aug 10
Price2.98
Change+4.56%
Gap+1.75%
Rel volume1.75×
Avg volume1.16M
Avg $ vol2.73M
SMA 202.13
SMA 501.88
SMA 2003.81
Price vs 50+58.44%
Price vs 200-21.78%
MA stackmixed
50/200 cross—
Supertrendup · 2.20
RSI (14)76
MACD hist0.10
MACD crossbull · 2d
Stoch %K / %D96 / 96
ADX (14)29
+DI / −DI45 / 11
RSI divergence—
MACD divergence—
ATR %+7.30%
ADR %9.76%
52w high7.17
52w low1.01
From 52w high-58.44%
Above 52w low+195.05%
New 52w highNo
SqueezeOff
Bollinger width63.80%
%B1.12
Donchian pos95.94%
Donchian high3.04
Donchian low1.68
AVWAP (52w high)2.88
vs AVWAP high+3.58%
AVWAP (52w low)4.01
vs AVWAP low-25.70%
OBV trendUp
Chaikin MF (20)0.23
Today vs 20d1.75×
Avg vol (14d)1.19M
Avg vol (20d)1.16M
Avg $ vol (20d)2.73M
Market cap206.39M
RS 3m (vs SPY)+53.52%
RS 6m (vs SPY)-47.68%
RS line new highYes
Trend template3/8
Technical rank44.8
1 week+58.51%
1 month+27.35%
3 months+69.32%
6 months-33.48%
1 year+150.42%
YTD-58.44%
P/E-2.30
P/B1.73
P/S—
P/FCF-2.52
EPS-2.12
Div yield—
ROE-75.00%
ROA-63.41%
Debt/Eq—
Current13.36
EV/EBITDA-1.99
Gross margin—
Net margin—
Rev growth—
EPS growth0.36%
Price target—
Target upside—
Analyst rating—
Institutional—
Ent. value183.63M
Revenue—
Net income-17.81M
Gross profit—
Free cash flow-81.9M
IndustryPHARMACEUTICAL PREPARATIONS
ExchangeNasdaq
Shares out69.17M
Employees59
ListedFri, May 6, 2022
Free float38.43M
Float %55.9%
Short interest4.53M
Days to cover2.9d
Short volume41.6%
Squeeze score51 / 100
Next earnings—
EPS forecast—
Last EPS vs est—
Last surprise—
Setup gradeB
Conviction64 / 100
Pattern quality—
Tech rank44.8 / 100
Group rank86 / 100 · Leading
Status laneNo active setup
Setup direction—
Pattern family
Resistance2.40
Support1.65
Days since event—
Candle confirm—
News sentiment—
Financials as of Tue, Jun 30, 2026 · quarterly.
Congress activity
Disclosed STOCK Act trades in PEPG
No recent disclosed trades by Congress in PEPG. STOCK Act filings can lag the trade by up to 45 days.
Insider activity
SEC Form 4 transactions in PEPG · 8 buys · 1 sell
| Insider | Side | Shares | Value | Traded | Filed |
|---|---|---|---|---|---|
Wyman Lisa Director · Stock Option (Right to Buy) · 2026-06-18 | Grant | 34K | — | 2026-06-18 | 2026-06-22 |
Resnick Joshua Director · Stock Option (Right to Buy) · 2026-06-18 | Grant | 34K | — | 2026-06-18 | 2026-06-22 |
Mayer Howard Director · Stock Option (Right to Buy) · 2026-06-18 | Grant | 34K | — | 2026-06-18 | 2026-06-22 |
Finer Mitchell H. Director · Stock Option (Right to Buy) · 2026-06-18 | Grant | 34K | — | 2026-06-18 | 2026-06-22 |
HENSON HEIDI Director · Stock Option (Right to Buy) · 2026-06-18 | Grant | 34K | — | 2026-06-18 | 2026-06-22 |
Dable Habib J Director · Stock Option (Right to Buy) · 2026-06-18 | Grant | 34K | — | 2026-06-18 | 2026-06-22 |
KEATING LAURIE Director · Stock Option (Right to Buy) · 2026-06-18 | Grant | 34K | — | 2026-06-18 | 2026-06-22 |
RA CAPITAL MANAGEMENT, L.P. Director · Stock Option (Right to Buy) · 2026-06-18 | Grant | 34K | — | 2026-06-18 | 2026-06-22 |
Kasraian Kasra Chief Technical Officer · Common Stock · 2026-05-21 | Sell | 1.23K | $2K | 2026-05-21 | 2026-05-26 |
SEC filings
EDGAR filings in PEPG · 3 recent
Get daily signals & real-time alerts.
StockSetups scans ~12,300 US stocks & ETFs after every close and sorts every long setup into four ranked lanes — each with a trade plan — plus an always-on engine firing 35+ real-time intraday alerts. Free for 14 days, cancel in one click.
Start free — 14-day full access →Educational data, not financial advice. Patterns, levels and the trade plan are algorithmic, not a recommendation to trade.